Le Lézard
Classified in: Health
Subjects: MAV, EXE, NTA

/R E P E A T -- Media advisory - Minister Philpott to deliver remarks at Public Policy Forum on Reconciliation & Health Care/


OTTAWA, Sept. 26, 2017 /CNW/ - Please be advised that the Honourable Jane Philpott, Minister of Indigenous Services, will deliver remarks at a Public Policy Forum of Canada conference entitled: "Partners in reconciliation: Recognizing and respecting Indigenous health".

After delivering remarks, Minister Philpott will be available to the media.

Date:
September 27, 2017

Time:
Remarks: 12:30 p.m. (EST)
Media availability: 1:05 p.m. (EST)  

Where:
National Arts Centre,
1 Elgin St.,
Ottawa, ON

Follow us on Twitter: @GCIndigenous
(
https://twitter.com/GCIndigenous)

 

SOURCE Indigenous and Northern Affairs Canada


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: